Malignant Melanoma

Showing NaN - NaN of 29

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumor, Castration-Resistant Prostatic Cancer, Malignant Melanoma Trial in United States (MGC018, lorigerlimab)

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • vobramitamab duocarmazine
  • lorigerlimab
  • Los Angeles, California
  • +7 more
Jan 10, 2023

Malignant Melanoma, NSCLC, Brain Tumors, Primary Trial in United States (PF-07284890, Binimetinib, Midazolam)

Recruiting
  • Malignant Melanoma
  • +4 more
  • Duarte, California
  • +71 more
Dec 29, 2022

Malignant Melanoma Trial in Worldwide (UV1, Sargramostim, Ipilimumab)

Recruiting
  • Malignant Melanoma
  • UV1
  • +3 more
  • Phoenix, Arizona
  • +39 more
Aug 16, 2022

Malignant Melanoma Trial in United States (BMS-936558 (MDX1106-04), Ipilimumab)

Completed
  • Malignant Melanoma
  • New Haven, Connecticut
  • +3 more
Mar 19, 2021

Malignant Melanoma Trial in New York (Imiquimod, NY-ESO-1 protein)

Completed
  • Malignant Melanoma
  • New York, New York
    NYU Cancer Institute
Sep 28, 2020

Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)

Terminated
  • Malignant Melanoma
  • +7 more
  • Gilbert, Arizona
  • +29 more
Sep 21, 2020

Malignant Melanoma Trial in New York, Oxford, Glasgow (IMCgp100)

Terminated
  • Malignant Melanoma
  • New York, New York
  • +2 more
Jul 1, 2020

Malignant Melanoma Trial in United Kingdom, United States (IMCgp100)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +8 more
Jul 1, 2020

Neuroblastoma, Rhabdomyosarcoma, Ewing's Sarcoma Trial in Worldwide (nab-paclitaxel)

Completed
  • Neuroblastoma
  • +22 more
  • Phoenix, Arizona
  • +19 more
Dec 19, 2019

Malignant Melanoma Trial in Australia, United States (Cobimetinib, vemurafenib)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +9 more
Jul 26, 2019

Malignant Melanoma Trial in Boston, New York (IMC-20D7S (Cohort 1A), IMC-20D7S (Cohort 2A), IMC-20D7S (Cohort 3A))

Completed
  • Malignant Melanoma
  • IMC-20D7S (Cohort 1A)
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 11, 2019

Malignant Melanoma Trial in Worldwide (Ipilimumab)

Terminated
  • Malignant Melanoma
  • Ipilimumab
  • Phoenix, Arizona
  • +31 more
Jul 31, 2017

Malignant Melanoma Trial in New York (ACY-241, nivolumab, ipilimumab)

Completed
  • Malignant Melanoma
  • New York, New York
    NYU Langone Medical Center
Aug 22, 2017

Malignant Melanoma, Colorectal Carcinoma Trial in Australia, United States (PLX4032)

Completed
  • Malignant Melanoma
  • Colorectal Carcinoma
  • Los Angeles, California
  • +6 more
Aug 18, 2017

Malignant Melanoma Trial in Australia, United States (vemurafenib)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +14 more
Jun 26, 2017

Malignant Melanoma Trial in United States (Vemurafenib)

Terminated
  • Malignant Melanoma
  • Tucson, Arizona
  • +14 more
Apr 24, 2017

Malignant Melanoma Trial in Canada, United States (Nivolumab, Ipilimumab)

No longer available
  • Malignant Melanoma
  • Gilbert, Arizona
  • +65 more
Feb 6, 2017

Malignant Melanoma Trial in Worldwide (vemurafenib)

Terminated
  • Malignant Melanoma
  • Los Angeles, California
  • +25 more
Aug 25, 2016

Malignant Melanoma Trial in Worldwide (Vemurafenib, Dacarbazine)

Completed
  • Malignant Melanoma
  • Birmingham, Alabama
  • +110 more
Aug 19, 2016

Malignant Melanoma Trial in United States (RO5185426)

Completed
  • Malignant Melanoma
  • Tucson, Arizona
  • +27 more
Jul 12, 2016

Melanoma, Malignant Melanoma Trial in Israel, United States (CT-011)

Completed
  • Melanoma
  • Malignant Melanoma
  • New Haven, Connecticut
  • +17 more
Dec 16, 2015

Malignant Melanoma Trial in New York (CP-461)

Terminated
  • Malignant Melanoma
  • New York, New York
    Columbia Presbyterian Medical Center
Oct 14, 2011

Melanoma, Metastatic Melanoma, Malignant Melanoma Trial in United States (Allovectin-7®)

Completed
  • Melanoma
  • +3 more
  • Allovectin-7®
  • Tucson, Arizona
  • +15 more
Jul 5, 2011